Movatterモバイル変換


[0]ホーム

URL:


AR081542A1 - Composiciones de emulsiones farmaceuticas con bajo contenido de aceite que comprenden un progestageno - Google Patents

Composiciones de emulsiones farmaceuticas con bajo contenido de aceite que comprenden un progestageno

Info

Publication number
AR081542A1
AR081542A1ARP110101417AARP110101417AAR081542A1AR 081542 A1AR081542 A1AR 081542A1AR P110101417 AARP110101417 AAR P110101417AAR P110101417 AARP110101417 AAR P110101417AAR 081542 A1AR081542 A1AR 081542A1
Authority
AR
Argentina
Prior art keywords
progestagen
understand
compositions
low oil
oil contents
Prior art date
Application number
ARP110101417A
Other languages
English (en)
Inventor
Laura Pickersgill
Hoiser Eva Di
Georg Maria-Achleitner
Original Assignee
Besins Healthcare Lu Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Besins Healthcare Lu SarlfiledCriticalBesins Healthcare Lu Sarl
Publication of AR081542A1publicationCriticalpatent/AR081542A1/es

Links

Classifications

Landscapes

Abstract

Composición de administración parenteral en forma de emulsión farmacéutica de aceite en agua, estéril y lista para usar, que comprende entre 0,015 y 0,5% p/v de progesterona; entre 0,5 y 10% p/v de aceite, donde el aceite comprende al menos 85% p/p de un triglicérido; entre 0,0425 y 4,1% p/v de un fosfolípido; entre 80 - 99,4% p/v de un medio acuoso; donde la composición tiene una osmolalidad en el rango de 200 - 1000 mOsm/kg. Uso de la composición mencionada con anterioridad en el tratamiento terapéutico o profiláctico, donde dicho tratamiento comprende la administración intravenosa de la emulsión farmacéutica.
ARP110101417A2010-04-262011-04-25Composiciones de emulsiones farmaceuticas con bajo contenido de aceite que comprenden un progestagenoAR081542A1 (es)

Applications Claiming Priority (6)

Application NumberPriority DateFiling DateTitle
EP101610292010-04-26
EP101610322010-04-26
EP101610342010-04-26
EP101957662010-12-17
EP101957642010-12-17
EP101957602010-12-17

Publications (1)

Publication NumberPublication Date
AR081542A1true AR081542A1 (es)2012-10-03

Family

ID=44001967

Family Applications (1)

Application NumberTitlePriority DateFiling Date
ARP110101417AAR081542A1 (es)2010-04-262011-04-25Composiciones de emulsiones farmaceuticas con bajo contenido de aceite que comprenden un progestageno

Country Status (23)

CountryLink
US (4)US8476252B2 (es)
EP (4)EP2857042B1 (es)
JP (1)JP5886273B2 (es)
KR (1)KR101822680B1 (es)
CN (2)CN102946865B (es)
AR (1)AR081542A1 (es)
AU (1)AU2011246527B2 (es)
BR (1)BR112012027279B1 (es)
CA (2)CA2797253C (es)
EA (1)EA022460B1 (es)
ES (4)ES2576190T3 (es)
GE (1)GEP20166457B (es)
HK (1)HK1181998A1 (es)
IL (2)IL222710A (es)
MX (1)MX2012012491A (es)
MY (1)MY156858A (es)
NZ (1)NZ603176A (es)
PH (1)PH12012502120B1 (es)
PL (1)PL2563335T3 (es)
PT (1)PT2563335E (es)
SG (1)SG185025A1 (es)
TW (1)TW201138782A (es)
WO (2)WO2011134937A2 (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
TW201138782A (en)2010-04-262011-11-16Besins Healthcare Lu SarlLow-oil pharmaceutical emulsion compositions comprising progestogen
WO2013078422A2 (en)2011-11-232013-05-30Therapeuticsmd, Inc.Natural combination hormone replacement formulations and therapies
US9301920B2 (en)2012-06-182016-04-05Therapeuticsmd, Inc.Natural combination hormone replacement formulations and therapies
IN2014DN08088A (es)*2012-02-292015-05-01Braun Melsungen Ag
TWI651098B (zh)*2012-02-292019-02-21B 柏藍麥桑根公司含荷爾蒙的乳劑
US10806740B2 (en)2012-06-182020-10-20Therapeuticsmd, Inc.Natural combination hormone replacement formulations and therapies
US20150196640A1 (en)2012-06-182015-07-16Therapeuticsmd, Inc.Progesterone formulations having a desirable pk profile
US10806697B2 (en)2012-12-212020-10-20Therapeuticsmd, Inc.Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en)2012-06-182013-12-19Therapeuticsmd, Inc.Transdermal hormone replacement therapies
US10537581B2 (en)2012-12-212020-01-21Therapeuticsmd, Inc.Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en)2012-12-212022-02-15Therapeuticsmd, Inc.Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en)2012-12-212019-11-12Therapeuticsmd, Inc.Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en)2012-12-212022-03-08Therapeuticsmd, Inc.Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en)2012-12-212015-11-10Therapeuticsmd, Inc.Soluble estradiol capsule for vaginal insertion
US10568891B2 (en)2012-12-212020-02-25Therapeuticsmd, Inc.Vaginal inserted estradiol pharmaceutical compositions and methods
EP2968140A4 (en)*2013-03-152016-11-16Pharmagenesis Inc INTRAVENOUS EMULSIONS OF TRIPTOLIDE AS IMMUNOMODULATORS AND ANTICROBIAL I
WO2015077717A1 (en)2013-11-252015-05-28The Broad Institute Inc.Compositions and methods for diagnosing, evaluating and treating cancer by means of the dna methylation status
WO2015085147A1 (en)2013-12-052015-06-11The Broad Institute Inc.Polymorphic gene typing and somatic change detection using sequencing data
US20160310584A1 (en)*2013-12-062016-10-27The Broad Institute Inc.Formulations for neoplasia vaccines
WO2015095811A2 (en)2013-12-202015-06-25The Board Institute Inc.Combination therapy with neoantigen vaccine
AU2015264003A1 (en)2014-05-222016-11-17Therapeuticsmd, Inc.Natural combination hormone replacement formulations and therapies
US10098894B2 (en)2014-07-292018-10-16Therapeuticsmd, Inc.Transdermal cream
EP3234130B1 (en)2014-12-192020-11-25The Broad Institute, Inc.Methods for profiling the t-cell- receptor repertoire
US10975442B2 (en)2014-12-192021-04-13Massachusetts Institute Of TechnologyMolecular biomarkers for cancer immunotherapy
CA2971786A1 (en)*2015-03-312016-10-06Fresenius Kabi Deutschland GmbhEmulsions for parenteral administration
BR112017024797A2 (pt)2015-05-202018-08-07The Broad Institute Inc.neoantígenos partilhados
US10328087B2 (en)2015-07-232019-06-25Therapeuticsmd, Inc.Formulations for solubilizing hormones
WO2017173044A1 (en)2016-04-012017-10-05Therapeuticsmd Inc.Steroid hormone compositions in medium chain oils
EP3435977A4 (en)2016-04-012019-10-16Therapeuticsmd, Inc. PHARMACEUTICAL COMPOSITION OF STEROID HORMONE
CN106074383B (zh)*2016-07-272019-03-08武汉科福新药有限责任公司孕激素药物脂微球注射液及其制备方法
US20180207097A1 (en)*2017-01-232018-07-26Government Of The United States As Represented By The Secretary Of The Air ForceNon-toxic vehicle to solubilize, deliver, and obtain biological activity of steroid hormones at cell, tissue, and organ targets, in vitro and in vivo
EP3574116A1 (en)2017-01-242019-12-04The Broad Institute, Inc.Compositions and methods for detecting a mutant variant of a polynucleotide
KR20210102936A (ko)*2018-12-102021-08-20헤일로 사이언스 엘엘씨안정적인 마취제 제제 및 관련 복용량 형태
US11633405B2 (en)2020-02-072023-04-25Therapeuticsmd, Inc.Steroid hormone pharmaceutical formulations
EP3878434A1 (en)*2020-03-122021-09-15Lipoid GmbHSunflower phospholipid composition containing phosphatidylcholine
US20230098327A1 (en)*2021-08-302023-03-30Premier Nutrition Company, LlcSleep-inducing beverage composition, its method of production and the method of use

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
JPS60258110A (ja)1984-06-051985-12-20Daigo Eiyou Kagaku Kk静脈注射可能なプロゲステロン乳化注射液
US5364632A (en)*1989-04-051994-11-15Yissum Research Development Company Of The Hebrew University Of JerusalemMedicinal emulsions
IL89856A (en)1989-04-051993-05-13Yissum Res Dev CoMedical emulsions for liphophilic drugs containing a medium-chain triglyceride oil as a carrier
SE9301171D0 (sv)*1993-04-071993-04-07Ab AstraPharmaceutical composition containing lipophilic drugs
SE9403389D0 (sv)1994-10-061994-10-06Astra AbPharmaceutical composition containing derivattves of sex hormones
HUP0202235A3 (en)1999-07-222004-05-28Aventis Pharmaceuticals Inc BrPreserved pharmaceutical formulations
US6720001B2 (en)*1999-10-182004-04-13Lipocine, Inc.Emulsion compositions for polyfunctional active ingredients
US6327968B1 (en)2000-03-172001-12-11Pizza Hut, Inc.System and method for producing par-baked pizza crusts
EP1488785A1 (de)2003-06-182004-12-22B. Braun Melsungen AgÖlemulsion zur postnatalen Hormonsubstitution
WO2005105040A2 (en)2004-04-262005-11-10Micelle Products, Inc.Water-soluble formulations of fat soluble vitamins and pharmaceutical agents and their applications
EP1611879B1 (en)2004-07-022009-08-12Novagali Pharma SAUse of emulsions for intra- and periocular injection
US7473687B2 (en)2005-03-242009-01-06Emory UniversityMethods for the treatment of a traumatic central nervous system injury
EP2431042B1 (en)2005-03-242013-06-26Emory UniversityMethods for the treatment of central nervous system injury via a tapered administration protocol
EP2001438A2 (en)*2006-02-092008-12-17Macusight, Inc.Stable formulations, and methods of their preparation and use
CN101152186B (zh)*2007-09-052011-07-06杭州平和安康医药科技有限公司黄体酮注射液及其制备方法
TW201138782A (en)2010-04-262011-11-16Besins Healthcare Lu SarlLow-oil pharmaceutical emulsion compositions comprising progestogen

Also Published As

Publication numberPublication date
ES2531646T3 (es)2015-03-18
CA2797253A1 (en)2011-11-03
CA2797141A1 (en)2011-11-03
CA2797141C (en)2018-05-15
WO2011134944A2 (en)2011-11-03
ES2606585T3 (es)2017-03-24
NZ603176A (en)2014-05-30
WO2011134937A2 (en)2011-11-03
EA201291108A1 (ru)2013-04-30
PT2563335E (pt)2015-03-31
WO2011134944A3 (en)2012-02-09
KR20130069638A (ko)2013-06-26
WO2011134937A3 (en)2012-02-02
KR101822680B1 (ko)2018-01-26
ES2576190T3 (es)2016-07-06
EP2801353B1 (en)2016-03-30
US20110262494A1 (en)2011-10-27
US20140335133A1 (en)2014-11-13
PL2563335T3 (pl)2015-05-29
TW201138782A (en)2011-11-16
AU2011246527B2 (en)2016-09-15
CA2797253C (en)2019-02-05
MX2012012491A (es)2013-02-15
IL222738A (en)2015-11-30
IL222710A0 (en)2012-12-31
PH12012502120B1 (en)2018-01-12
BR112012027279B1 (pt)2020-12-29
US8476252B2 (en)2013-07-02
BR112012027279A2 (pt)2018-05-15
MY156858A (en)2016-04-15
US8765149B2 (en)2014-07-01
GEP20166457B (en)2016-04-11
SG185025A1 (en)2012-11-29
JP2013525402A (ja)2013-06-20
IL222738A0 (en)2012-12-31
JP5886273B2 (ja)2016-03-16
IL222710A (en)2015-11-30
PH12012502120A1 (en)2013-02-04
EP2563334B1 (en)2014-07-16
US20110262495A1 (en)2011-10-27
EP2801353A1 (en)2014-11-12
EP2857042A1 (en)2015-04-08
EA022460B1 (ru)2016-01-29
CN102946865B (zh)2016-06-22
CN102946864A (zh)2013-02-27
US20140147474A1 (en)2014-05-29
CN102946865A (zh)2013-02-27
EP2857042B1 (en)2016-08-31
US9572818B2 (en)2017-02-21
EP2563335B1 (en)2014-12-17
EP2563335A2 (en)2013-03-06
ES2514690T3 (es)2014-10-28
EP2563334A2 (en)2013-03-06
AU2011246527A1 (en)2012-11-15
HK1181998A1 (en)2013-11-22

Similar Documents

PublicationPublication DateTitle
AR081542A1 (es)Composiciones de emulsiones farmaceuticas con bajo contenido de aceite que comprenden un progestageno
CR20220108A (es)Nanopartículas lipídicas mejoradas para el suministro de ácidos nucleicos
CL2017001488A1 (es)Benzamidas sustituidas con 1,3–tiazol–2–ilo
BR112018067586A2 (pt)composição administrável oralmente
AR088382A1 (es)Formulaciones de etanercept estabilizadas con xilitol
GT201500086A (es)Análogos de 2'-cloro nucleósido para infección por vhc
PE20180038A1 (es)Composiciones farmaceuticas topicas
BR112014026118A2 (pt)métodos relacionados a composições para cuidados pessoais
PE20131166A1 (es)Formulacion de premezcla de dexmedetomidina
BR112014004460A2 (pt)material polimérico para um recipiente isolado
AR099632A1 (es)Tratamiento de una infección viral de hepatitis c, que usa una combinación de compuestos
MX2016007658A (es)Composiciones basadas en metil ciclodextrinas para el tratamiento y/o prevencion de enfermedades aumentando el nivel de colesterol hdl.
CL2016002276A1 (es)Composiciones tópicas que comprenden un extracto de coriolus versicolor para aumentar la autoinmunidad
MX377302B (es)Composiciones para el cuidado personal con dos fases benéficas.
CL2018003110A1 (es)Preparación y dispersión de formulaciones de emulsión estable.
CL2016002400A1 (es)Formulación para higiene personal
CL2012003341A1 (es)Composicion farmaceutica de administracion oral que compende bendamustina o un ester, una sal o un solvato de la misma, y un excipiente que es un agente tensioactivo no ionico e hidrofilico; combinacion farmaceutica; y su uso para el tratamiento de leucemia linfocitica cronica y el mieloma multiple, entre otras enfermedades.
CL2012003282A1 (es)Composicion farmaceutica topica que comprende, en base al peso total de la composicion a) 0,01 a 0,2% en peso de furoato de mometasona, b) 5 a 18% en peso de hexilenglicol, c) 20 a 40% en peso de agua y d) 25 a 70% en peso de una fase oleosa; y su uso para tratar o prevenir psoriasis, dermatitis atopica, entre otros.
BR112017006918A2 (pt)formulações nanoestruturadas para liberação de silibinina e outros ingredientes ativos para o tratamento de doenças oculares
PE20170305A1 (es)Combinacion sinergistica de paracetamol/celecoxib para el tratamiento de dolor inflamatorio
UY30676A1 (es)Microemulsion aceite/agua de propofol estable y lista para uso
CL2015001368A1 (es)Metodo para anticoncepcion controlada que comprende administrar una preparacion farmaceutica que comprende levonorgestrel y un inhibidor de la cox; uso de la composicion farmaceutica en la anticoncepcion "a la carta".
BR112016006485A2 (pt)composições de liberação pulsátil revestidas por compressão
MX2015008330A (es)Composiciones farmaceuticas veterinarias novedosas y un metodo para la produccion de las mismas.
TN2012000505A1 (en)Low-oil pharmaceutical emulsion compositions comprising progestogen

Legal Events

DateCodeTitleDescription
FCRefusal

[8]ページ先頭

©2009-2025 Movatter.jp